Greenstone Recalls Spironolactone Tablets Due to Unapproved Manufacturing Site Change
Greenstone LLC is recalling 4,848 bottles of Spironolactone 50 mg tablets because the manufacturing site change resulted in an unapproved dissolution profile.
- Product
- Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1
- Category
- Drug
- Distribution
- Distributed nationwide